Pieter Cohen, associate professor of medicine at Harvard Medical School and a recognized expert in supplement safety, has noted: "Whenever you bypass the gut and deliver a compound intravenously, you remove the body's first line of pharmacokinetic regulation
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease Sikiric P, Seiwerth S, et al
hence, the increase in ROS level leads to increased protein carbonylation level, showing that cells are subjected to more serious oxidative damage
The treatment of inflammatory bowel illnesses (IBD), including Crohns disease, gastric ulcers, and ulcerative colitis, is one of the main areas where BPC-157 exhibits promise in clinical trials
For actin regulation to meaningfully remodel damaged tissue, the signaling environment needs to be maintained across weeks, not days